One proposed mechanism via which VNS exerts its cardioprotective effects in HF is through the normalisation of NO signalling pathways, specifically with the calibration of nNOS expression in the myocardium (Sabbah et al., 2011; Kalla et al., 2016). The gene discussed is NOS1; the disease is hydrops fetalis.